Oncology: SE Medications Flashcards
1
Q
Neupogen
A
- Filgrastim
- CSF
- Injected QD (IV/SQ)
2
Q
Neulasta
A
- Pegfilgrastim
- Pegylated CSF
- Administered SQ once per chemo cycle
3
Q
CSF Information
A
- SE: Bone pain
- More severe SE in sargramostim (limited to stem cell transplantation)
- Store in fridge
- Report any signs of enlarged spleen (pain in upper, left abdomen)
- Document when pegfilgrastim is given (min. of 12 days between administrations)
4
Q
Procrit
A
- Epoetin Alfa
- AKA Epogen
- ESA for anemia in NON-curative cancer
5
Q
Aranesp
A
- Darbepoetin alfa
- ESA for anemia in NON-curative cancer
6
Q
NK1-RA Examples
A
- Aprepitant PO
- Dosaprepitant IV
- Rolapitant
7
Q
Akynzeo (PO)
A
-Netupitant/palonosetron PO
8
Q
Akynzeo (IV)
A
-Fosnetupitant/palonosetron IV
9
Q
Emend (PO)
A
- Aprepitant
- NK1-RA
- Inhibits acute and delayed CINV
- Decrease dexamethasone dose if used concurrently, CYP3A4i
10
Q
Emend (IV)
A
- Fosaprepitant
- NK1-RA
- Inhibits acute/delayed phases of CINV
- Decrease dexamethasone dose if used concurrently, CYP3A4i
11
Q
Zuplenz
A
- Ondansetron, film formulation
- 5HT3-RA
- Can be given day 1 of chemo
12
Q
Sancruso
A
- Granisetron
- 5HT3-RA
- Patch: apply 24-48 hours BEFORE chemo
13
Q
Aloxi
A
- Palonosetron
- 5HT3-RA
- Can be given day 1 of chemo
14
Q
Dolasetron
A
- 5HT3-RA NOT indicated for CINV
- Increases risk for QT prolongation
15
Q
5HT3-RA Information
A
- CI: Do not use with apomorphine (severe HTN/loss of consciousness)
- Increases QT interval based on dose, 5HT syndrome risk
- SE: HA, constipation